Navigation Links
EpiVax Reports $5.2 Million for New Q Fever Vaccine Means There is Hope for Vaccines On Demand
Date:6/11/2015

PROVIDENCE, R.I., June 11, 2015 /PRNewswire/ -- EpiVax reports today that the Defense Threat Reduction Agency (DTRA) is investing $5.2 Million for the development of a new type of vaccine against Q fever. Academic and industry organizations from around the world, led by Mark Poznansky of the Vaccine and Immunotherapy Center (VIC) and Massachusetts General Hospital and Annie De Groot of EpiVax (Providence, Rhode Island) have joined forces to focus on rapid vaccine development for emerging infectious disease. The VaxCelerate consortium includes collaborators from Colorado State University in Fort Collins; InnatOss Laboratories in Oss, the Netherlands and Yale University in New Haven, Connecticut.

EpiVax contributes first-in-class immunoinformatics tools to speed the pace of vaccine development and provide rapid clues about the likelihood of success in human trials. "EpiVax has worked hard to be at the forefront of the 'vaccines on demand' concept.  Their selection as a partner in this project recognizes their leadership in terms of developing safer, more efficient vaccines and improving our national biodefense rapid response capabilities," stated U.S. Senator Jack Reed (D-RI), the Ranking Member of the Armed Services Committee.

Following a delayed response to the H1N1 flu in 2009, the U.S. federal government has made major investments in rapid vaccine manufacturing approaches. The VaxCelerate effort received early funding from the Defense Advanced Research Programs Agency (DARPA) to integrate cutting-edge technologies into an end-to-end vaccine development process. The consortium was able to successfully develop and test a new vaccine for Lassa fever in 120 days, starting only from genomic data on the virus. The current DTRA-funded project focuses on the development of an RNA-based vaccine that will promote protective responses against the Q fever bacteria without the potential safety issues that prevent existing vaccine candidates from receiving US regulatory approval for use in humans.

About EpiVax
EpiVax is a biotechnology company based in Providence, Rhode Island with expertise in immunology, immunoinformatics, immunogenicity screening, deimmunization, and immune modulation. EpiVax leverages computational tools to engineer safer, more effective therapeutic proteins and rapidly design protective and efficacious new vaccines.
http://www.epivax.com/

About Q Fever
Q fever is a worldwide disease caused by the bacteria Coxiella burnetii. Humans are susceptible to the disease, and few organisms may be required to cause infection.
http://www.cdc.gov/qfever/

CONTACT:
Steven Vessella
401-272-2123
svessella@epivax.com

Logo - http://photos.prnewswire.com/prnh/20121116/NE15175LOGO


'/>"/>
SOURCE EpiVax
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting
2. Cantel Medical Reports Results For The Third Quarter Ended April 30, 2015
3. VirtualScopics, Inc. Reports Voting Results At Annual Meeting Of Shareholders; All Board Seats Renewed
4. Cyberonics Reports Quarter And Annual Results
5. U.S. Pet Medications Market to Reach $10 Billion by 2018, Remains Hotbed for Intense Competition, finds Reports by Packaged Facts and the FTC
6. MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results
7. Global Sanitation Fund Reports Major Sanitation & Hygiene Advances for Seven Million People in 13 Countries
8. Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015
9. BioLight Reports First Quarter 2015 Financial Results
10. TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict.
11. Essa Pharma Inc. Reports Second Quarter 2015 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2018)... ... ... Cardiologist Ernst von Schwarz, MD says that women can experience unique warning ... by their doctors. “This can be especially dangerous in younger women who may not ... symptoms that are unique to women so they may become better advocates for themselves ...
(Date:12/6/2018)... ... 06, 2018 , ... Last year, 172 children deaths were reported for the ... not gotten the vaccine. Vaccination is the first step in protecting against the flu ... of the illness if infected. Along with getting vaccinated, people can take active steps ...
(Date:12/6/2018)... Ariz. (PRWEB) , ... December 06, 2018 , ... ... new website and with it, more answers for the millions of Americans and ... than the other available treatment facilities, the renowned Alternative to Meds Center utilizes ...
Breaking Medicine Technology:
(Date:12/5/2018)... ... December 05, 2018 , ... Body ... first plastic surgery practices in Houston to offer the BodyTitePRO treatment. Dr. ... an innovative range of surgical and noninvasive techniques to improve the face, breast ...
(Date:12/5/2018)... ... 05, 2018 , ... Marking its seventh year, Pacifica Graduate Institute Alumni ... ‘Round the World” on New Year’s Eve. Each year event organizer and Director ... faculty members, staff, families, and friends of the institution) to join the celebration. ...
(Date:12/5/2018)... ... 2018 , ... Since PermaLip™ implants are solid, patients do not ... naked eye, ensuring a natural look. “I always double and triple check implant placement ... implant visibility,” says Dr. Jessica Kulak, double board certified facial plastic surgeon at The ...
(Date:12/5/2018)... Colo. (PRWEB) , ... December 05, 2018 , ... Dr. ... gum disease treatment and LAPIP™ protocol for ailing dental implants in the Fort Collins ... minimally invasive treatment proven to regenerate the bone and tissues lost to gum disease. ...
(Date:12/5/2018)... ... 2018 , ... Earthly Mist, Edmond, Oklahoma’s newest medical marijuana ... The dispensary will serve Edmond, Oklahoma residents who present a current Oklahoma state-issued ... the correct medical cannabis product based on their doctor’s recommendations. Licensed minor patients ...
Breaking Medicine News(10 mins):